Valence ロゴ
人気
ログイン

ウォッチリストに追加

Ascentage Pharma Group In...

NasdaqGM: AAPG · リアルタイム株価 · USD
16.71
-0.73 (-4.19%)
終値時点： Aug 24, 2026, 2:00 PM

株価、主要な数字、最新ニュースをひとまとめにしたページです。

Ascentage Pharma Group Internat（AAPG）の株価・分析・データ

-4.19%
買気配18.19
時価総額1.56B
売上高（TTM）642.64M
純利益（TTM）-1.47B
n/a
-2.31
n/a
-12.4
PBR（TTM）18.82
PSR（TTM）2.43
決算発表日Aug 7, 2025
売気配23.14
出来高5,946
平均出来高（20日）11,136
始値16.83
前日終値17.44
当日レンジ16.70 - 16.91
52週レンジ16.36 - 43.45
アナリストStrong Buy
目標株価47 (181.27%)
配当n/a
権利落ち日n/a

AAPGについて

Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation. It also develops APG-2575, an oral administered Bcl-2 selective inhibitor for hematologic malignancies and solid tumors; A...

[続きを読む]
業種 Biotechnology
セクター Healthcare
IPO日 Jan 24, 2025
従業員数 767
上場取引所 NasdaqGM
ティッカー AAPG
ウェブサイト https://www.ascentage.cn
企業情報の全文

業績

2025年のAscentage Pharma Internatの売上高は574.12Mで、前年の980.65Mから-41.46%の減少でした。 利益は-1.24Bで、206.53%の増加でした。

財務諸表

アナリスト予想

9件のアナリスト評価によると、AAPG株の平均レーティングは「Strong Buy」です。12か月後の目標株価は47で、直近株価から181.27%の上昇余地となります。

株価予想

次回決算発表

Ascentage Pharma Group Internatの決算発表予定日は Aug 7, 2025, 寄り付き前の予定です。
アナリストの売上高予想は ... アップグレード
news image

4日前 · MarketBeat

Ascentage Pharma Group International H1 Earnings Call Highlights

Ascentage Pharma Group International (NASDAQ:AAPG) reported first-half 2026 revenue growth as it continued investing in global registrational studies for its hematology-oncology pipeline and began bui...

news image

4週間前 · Zacks

Wall Street Analysts Predict a 160.09% Upside in Ascentage Pharma Group International - Unsponsored ADR (AAPG): Here's What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 160.1% in Ascentage Pharma Group International - Unsponsored ADR (AAPG). While the effectiveness of this highly...

news image

1か月前 · Zacks

How Much Upside is Left in Ascentage Pharma Group International - Unsponsored ADR (AAPG)? Wall Street Analysts Think 152.23%

The consensus price target hints at a 152.2% upside potential for Ascentage Pharma Group International - Unsponsored ADR (AAPG). While empirical research shows that this sought-after metric is hardly ...

news image

1か月前 · Insider Monkey

Why Ascentage Pharma Group Internat (AAPG) Is Gaining Attention in Cancer Drug Development

We recently compiled a list of the 10 Best Biotech Stocks to Buy According to Analysts. Ascentage Pharma Group Internat (NASDAQ:AAPG) is one of the best biotech stocks on this list. TheFly reported on...

news image

2か月前 · Simply Wall St.

A Look At Ascentage Pharma Group International’s Valuation After Recent Share Price Weakness

Recent share performance and what it may signal Ascentage Pharma Group International (SEHK:6855) has been on many watchlists after a sharp pullback, with the stock down 2.9% in the latest session and ...

2ページ中1ページ